Range Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Buy |
55,280
+3,140
| +6% | +$145K | 1.01% | 26 |
|
|
2025
Q1 | $3.18M | Buy |
52,140
+2,945
| +6% | +$180K | 1.41% | 13 |
|
|
2024
Q4 | $2.78M | Buy |
49,195
+43,495
| +763% | +$2.46M | 1.28% | 14 |
|
|
2024
Q3 | $295K | Buy |
+5,700
| New | +$295K | 0.41% | 62 |
|
|
2024
Q2 | – | Sell |
-34,942
| Closed | -$1.89M | – | 179 |
|
|
2024
Q1 | $1.89M | Buy |
34,942
+5,651
| +19% | +$306K | 0.98% | 22 |
|
|
2023
Q4 | $1.5M | Buy |
29,291
+645
| +2% | +$33.1K | 0.9% | 31 |
|
|
2023
Q3 | $1.66M | Buy |
28,646
+234
| +0.8% | +$13.6K | 1.1% | 18 |
|
|
2023
Q2 | $1.82M | Buy |
28,412
+15,775
| +125% | +$1.01M | 1.15% | 14 |
|
|
2023
Q1 | $876K | Sell |
12,637
-434
| -3% | -$30.1K | 0.57% | 67 |
|
|
2022
Q4 | $940K | Buy |
13,071
+67
| +0.5% | +$4.82K | 0.64% | 59 |
|
|
2022
Q3 | $924K | Buy |
13,004
+91
| +0.7% | +$6.47K | 0.71% | 56 |
|
|
2022
Q2 | $994K | Sell |
12,913
-851
| -6% | -$65.5K | 0.72% | 55 |
|
|
2022
Q1 | $1.01M | Buy |
13,764
+750
| +6% | +$54.8K | 0.64% | 61 |
|
|
2021
Q4 | $811K | Buy |
13,014
+527
| +4% | +$32.8K | 0.53% | 80 |
|
|
2021
Q3 | $739K | Buy |
12,487
+331
| +3% | +$19.6K | 0.53% | 75 |
|
|
2021
Q2 | $812K | Buy |
12,156
+2,124
| +21% | +$142K | 0.6% | 65 |
|
|
2021
Q1 | $633K | Buy |
+10,032
| New | +$633K | 0.58% | 76 |
|